PET-ONLY 18F-AV1451 TAU QUANTIFICATION

被引：0
|
作者：
Bourgeat, P. [1 ]
Villemagne, V. L. [2 ,4 ]
Dore, V. [1 ,4 ]
Masters, C. L. [2 ]
Ames, D. [3 ]
Rowe, C. C. [4 ]
Salvado, O. [1 ]
Fripp, J. [1 ]
机构：
[1] CSIRO, Hlth & Biosecur, Canberra, ACT, Australia
[2] Mental Hlth Res Inst, Parkville, Vic, Australia
[3] Natl Ageing Res Inst, Parkville, Vic, Australia
[4] Dept Nucl Med & Ctr PET, Parkville, Vic, Australia
来源：
2017 IEEE 14TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI 2017) | 2017年
基金：
美国国家卫生研究院; 加拿大健康研究院;
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
In vivo tau imaging with PET is a promising new modality that offers a unique insight into Alzheimer's disease (AD) pathology. F-18-AV1451 is a tau tracer currently being evaluated in both AIBL and ADNI. While MR-based quantification remains the gold standard, there is great interest in PET-only quantification techniques for use in patients who cannot undergo MRI. In this study, 3 PET-only methods (single atlas, adaptive atlas, and PCA-based atlas) are evaluated and compared to an MR-based quantification in both AIBL (94 subjects) and ADNI (87 subjects). Results show that all quantifications performed using PET-only normalization approaches did equally well, with an average quantification error around 2% in both cohorts.
引用
收藏
页码：1173 / 1176
页数：4
相关论文
共 50 条
  • [21] 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
    Smith, Ruben
    Puschmann, Andreas
    Scholl, Michael
    Ohlsson, Tomas
    van Swieten, John
    Honer, Michael
    Englund, Elisabet
    Hansson, Oskar
    BRAIN, 2016, 139 : 2372 - 2379
  • [22] Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology
    Hahn, Andreas
    Schain, Martin
    Erlandsson, Maria
    Sjolin, Petter
    James, Gregory M.
    Strandberg, Olof T.
    Hagerstrom, Douglas
    Lanzenberger, Rupert
    Jogi, Jonas
    Olsson, Tomas G.
    Smith, Ruben
    Hansson, Oskar
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (04) : 623 - 631
  • [23] Test-Retest Data for the Tau PET Imaging Agent 18F-AV-1451
    Devous, M. D.
    Joshi, A. D.
    Navitsky, M. A.
    Dixon, J.
    Pontecorvo, M. J.
    Siderowf, A.
    Mintun, M. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S260 - S260
  • [24] PET IMAGING OF TAU PATHOLOGY USING [18F]AV-1451 IN CHRONIC TBI
    Okonkwo, David
    Presson, Nora
    Minhas, Davneet
    Laymon, Charles
    Lopresti, Brian
    Mathis, Chet
    Schneider, Walter
    Mountz, James
    JOURNAL OF NEUROTRAUMA, 2016, 33 (13) : A92 - A92
  • [25] Evaluation of Partial Volume Correction on Quantitation of the PET Tau Tracer, 18F-AV-1451
    Southekal, Sudeepti
    Dickson, James
    Joshi, Abhinay
    Navitsky, Michael
    Pontecorvo, Michael
    Lu, Ming
    Mintun, Mark
    Devous, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [26] Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging
    Kim, Hee Jin
    Park, Seongbeom
    Cho, Hanna
    Jang, Young Kyoung
    Lee, Jin San
    Jang, Hyemin
    Kim, Yeshin
    Kim, Ko Woon
    Ryu, Young Hoon
    Choi, Jae Yong
    Moon, Seung Hwan
    Weiner, Michael W.
    Jagust, William J.
    Rabinovici, Gil D.
    DeCarli, Charles
    Lyoo, Chul Hyoung
    Na, Duk L.
    Seo, Sang Won
    JAMA NEUROLOGY, 2018, 75 (08) : 999 - 1007
  • [27] Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects
    Wooten, Dustin W.
    Guehl, Nicolas J.
    Verwer, Eline E.
    Shoup, Timothy M.
    Yokell, Daniel L.
    Zubcevik, Nevena
    Vasdev, Neil
    Zafonte, Ross D.
    Johnson, Keith A.
    El Fakhri, Georges
    Normandin, Marc D.
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (03) : 484 - 491
  • [28] Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample
    La Joie, Renaud
    Bejanin, Alexandre
    Fagan, Anne M.
    Ayakta, Nagehan
    Baker, Suzanne L.
    Bourakova, Viktoriya
    Boxer, Adam L.
    Cha, Jungho
    Karydas, Anna
    Jerome, Gina
    Maass, Anne
    Mensing, Ashley
    Miller, Zachary A.
    O'Neil, James P.
    Pham, Julie
    Rosen, Howard J.
    Tsai, Richard
    Visani, Adrienne V.
    Miller, Bruce L.
    Jagust, William J.
    Rabinovici, Gil D.
    NEUROLOGY, 2018, 90 (04) : E282 - +
  • [29] In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms
    Jones, David T.
    Knopman, David S.
    Graff-Radford, Jonathan
    Syrjanen, Jeremy A.
    Senjem, Matthew L.
    Schwarz, Christopher G.
    Dheel, Christina
    Wszolek, Zbigniew
    Rademakers, Rosa
    Kantarci, Kejal
    Petersen, Ronald C.
    Jack, Clifford R., Jr.
    Lowe, Val J.
    Boeve, Bradley F.
    NEUROLOGY, 2018, 90 (11) : E947 - +
  • [30] Combining categorical and continuous tau burden measures from four different tau tracers: 18F-AV1451, 18F-THK5317, 18F-THK5351, and 18F-MK6420
    Villemagne, Victor
    Dora, Vincent
    Burnham, Samantha
    Bourgeat, Pierrick
    Cummins, Tia
    Mulligan, Rachel
    Williams, Robert
    Salvado, Olivier
    Masters, Colin
    Rowe, Christopher
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
12345